发明授权
US07144913B2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
有权
二氢吡咯并[1,2-a]吲哚和四氢吡啶并[1,2-a] - 吲哚衍生物作为前列腺素d2受体拮抗剂
- 专利标题: Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
- 专利标题(中): 二氢吡咯并[1,2-a]吲哚和四氢吡啶并[1,2-a] - 吲哚衍生物作为前列腺素d2受体拮抗剂
-
申请号: US10474929申请日: 2002-05-22
-
公开(公告)号: US07144913B2公开(公告)日: 2006-12-05
- 发明人: Zhaoyin Wang , Christian Beaulieu , Claude Dufresne , Daniel Guay , Yves LeBlanc
- 申请人: Zhaoyin Wang , Christian Beaulieu , Claude Dufresne , Daniel Guay , Yves LeBlanc
- 申请人地址: CA Kirkland
- 专利权人: Merck Frosst Canada & Co.
- 当前专利权人: Merck Frosst Canada & Co.
- 当前专利权人地址: CA Kirkland
- 代理商 David L. Rose
- 国际申请: PCT/CA02/00745 WO 20020522
- 国际公布: WO02/094830 WO 20021128
- 主分类号: A61K31/40
- IPC分类号: A61K31/40 ; C07D487/00
摘要:
Dihydropyrroloindoles and tetrahydropyridoindoles are prostaglandin receptor antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.
公开/授权文献
信息查询